ANNOUNCEMENT 04 Mar 2019

This investment was made through Canada’s Strategic Innovation Fund, which aims to accelerate economic growth, strengthen and expand the role of Canadian firms in regional and global supply chains, support economic strategies, and attract investment.

 

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising
Inception date: 04 Mar 2019 | Removal date: open ended

Financial grant

On March 4, 2019 the Government of Canada announced a Can.$37.5 million (U.S.$28.3 million) subsidy to the biotechnology company BioVectra Inc. The company is a producer and a supplier of various reagents to the biotechnology and pharmaceutical industry.

This investment is being made through the Strategic Innovation Fund, a program that is “designed to attract and support high-quality business investments across all sectors of the economy by encouraging R&D that will accelerate the transfer of technology and the commercialization of innovative products, processes and services and will facilitate the growth of innovative firms.”

AFFECTED SECTORS